Loading...
Creades AB
0QI9.L•LSE
Financial Services
Financial - Diversified
£77.24
£-1.86(-2.35%)
Creades AB (0QI9.L) Financial Performance & Income Statement Overview
Review Creades AB’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
139.03%
↑ 139.03%
Operating Income Growth
130.27%
↑ 130.27%
Net Income Growth
115.41%
↑ 115.41%
Operating Cash Flow Growth
-7.32%
↓ 7.32%
Operating Margin
90.56%
↑ 90.56%
Gross Margin
138.60%
↑ 138.60%
Net Profit Margin
91.07%
↑ 91.07%
ROE
14.16%
↑ 14.16%
ROIC
13.50%
↑ 13.50%
Creades AB (0QI9.L) Income Statement & Financial Overview
Review Creades AB's (0QI9.L) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $198.00M | $349.00M | $177.00M | $833.00M |
Cost of Revenue | $0.00 | $0.00 | $0.00 | -$601.00M |
Gross Profit | $198.00M | $349.00M | $177.00M | $1.43B |
Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.72 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $11.00M | $62.00M | -$5.00M | $67.00M |
Operating Expenses | $20.00M | $62.00M | $177.00M | $66.00M |
Total Costs & Expenses | $20.00M | $62.00M | $177.00M | $66.00M |
Interest Income | $0.00 | $5.00M | $4.00M | $4.00M |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $0.00 | $0.00 | $0.00 | $250000.00 |
EBITDA | $176.00M | $0.00 | $178.00M | $767.25M |
EBITDA Ratio | $0.89 | $0.00 | $1.006 | $0.92 |
Operating Income | $178.00M | $287.00M | $178.00M | $767.00M |
Operating Income Ratio | $0.90 | $0.82 | $1.006 | $0.92 |
Other Income/Expenses (Net) | $0.00 | $0.00 | $4.00M | $4.00M |
Income Before Tax | $178.00M | $287.00M | $182.00M | $771.00M |
Income Before Tax Ratio | $0.90 | $0.82 | $1.03 | $0.93 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Net Income | $178.00M | $287.00M | $182.00M | $771.00M |
Net Income Ratio | $0.90 | $0.82 | $1.03 | $0.93 |
EPS | $1.31 | $2.11 | $1.34 | $5.68 |
Diluted EPS | $1.31 | $2.11 | $1.34 | $5.68 |
Weighted Avg Shares Outstanding | $135.76M | $135.76M | $135.76M | $135.76M |
Weighted Avg Shares Outstanding (Diluted) | $135.76M | $135.76M | $135.76M | $135.76M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan